Publications

2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2001-2005 | 1996-2000 |

Scientific publications

This section includes a chronological list of scientific publications published by the clinical research groups connected to ATHENA/SHM. 

 

2012


Episodes of HIV Viremia and the Risk of Non-AIDS Diseases in Patients on Suppressive Antiretroviral Therapy.
Zhang S, van Sighem A, Kesselring A, Gras L, Smit C, Prins JM, Kauffmann R, Richter C, de Wolf F, Reiss P.
J Acquir Immune Defic Syndr. 2012 Apr 23. [Epub ahead of print] Article

The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study.
The HIV-CAUSAL Collaboration.
AIDS. 2012 Apr 26. [Epub ahead of print] Article

Temporary antiretroviral treatment during primary HIV-1 infection has a positive impact on health-related quality of life: data from the Primo-SHM cohort study.
The Primo-SHM study group.
HIV Med. 2012 Apr 25. doi: 10.1111/j.1468-1293.2012.01020.x. [Epub ahead of print] Article

All-cause mortality in treated HIV-infected adults with CD4 >=500/mm3 compared with the general population: evidence from a large European observational cohort collaboration
Lewden C, Bouteloup V, De Wit S, Sabin C, Mocroft A, Wasmuth JC, van Sighem A, Kirk O, Obel N, Panos G, Ghosn J, Dabis F, Mary-Krause M, Leport C, Perez-Hoyos S, Sobrino-Vegas P, Stephan C, Castagna A, Antinori A, d'Arminio Monforte A, Torti C, Mussini C, Isern V, Calmy A, Teira R, Egger M, Grarup J, Chêne G voor The Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord
Int J Epidemiol. 2012 Apr;41(2):433-445 Article

Developing a multidisciplinary network for clinical research on HIV infection: the EuroCoord experience
Frank de Wolf, Caroline Sabin, Ole Kirk, Claire Thorne, Genevieve Chene & Kholoud Porter
Clin. Invest. (2012) 2(3), 255–264 Article 
 
No Treatment versus 24 or 60 Weeks of Antiretroviral Treatment during Primary HIV Infection: The Randomized Primo-SHM Trial Marlous L. Grijsen, Radjin Steingrover, Ferdinand W. N. M. Wit, Suzanne Jurriaans, Annelies Verbon, Kees Brinkman, Marchina E. van der Ende, Robin Soetekouw, Frank de Wolf, Joep M. A. Lange, Hanneke Schuitemaker, Jan M. Prins, on behalf of the Primo-SHM Study Group
PloS Medicine March 2012 Abstract 
 
CD4 Cell Count and the Risk of AIDS or Death in HIV-Infected Adults on Combination Antiretroviral Therapy with a Suppressed Viral Load: A Longitudinal Cohort Study from COHERE.
 
The Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord.
PLoS Med. 2012 Mar;9(3):e1001194. Epub 2012 Mar 20 Abstract
 
Calendar time trends in the incidence and prevalence of triple-class viroligic failure in antiretroviral drug experienced people with HIV in Europe.
Nakagawa F for the PLATO II group for COHERE in EuroCoord.
JAIDS 2012 Mar 1;59(3):294-9 Abstract
 
Evaluation of HIV Protease Inhibitor Use and the Risk of Sudden Death or Nonhemorrhagic Stroke.
Worm SW, Kamara DA, Reiss P, Fontas E, De Wit S, El-Sadr W, D'Arminio Monforte A, Law M, Phillips A, Ryom L, Dabis NF, Weber R, Sabin C, Lundgren JD; on behalf of the D:A:D Study Group.
J Infect Dis. 2012 Feb;205(4):535-9. Epub 2012 Jan 5. Abstract
 
Long-term complications in patients with poor immunological recovery despite virological successful HAART in Dutch ATHENA cohort
Van Leyveld S F L, Gras L, Kesselring A, Zhang S, de Wolf F, Wensing A M J, Hoepelman A I M, on behalf of the ATHENA national observational cohort study
AIDS 2012, Feb 20;26(4):465-474 Abstract
 
Single Nucleotide Polymorphism in Gene Encoding Transcription Factor Prep1 Is Associated with HIV-1-Associated Dementia
Bol S M, Booiman T, van Manen D, Bunnik E M, van Sighem A I, Sieberer M, Boeser-Nunnink B, de Wolf F, Schuitemaker H, Portegies P, Kootstra N A, van ’t Wout A B
PloS ONE February 2012 | Volume 7 | Issue 2 | e30990
 
The clinical interpretation of viral blips in HIV patients receiving antiviral treatment: are we ready to infer poor adherence?
Chun-Hai Fung I, Gambhir M, van Sighem A, de Wolf F, Garnett GP.
J Acquir Immune Defic Syndr. 2012 Jan 19. [Epub ahead of print]. Abstract
 
Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmission.
Herbeck JT, Müller V, Maust BS, Ledergerber B, Torti C, Di Giambenedetto S, Gras L, Günthard HF, Jacobson LP, Mullins JI, Gottlieb GS.
AIDS. 2012 Jan 14;26(2):193-205. Abstract
 
 
 

© Stichting HIV Monitoring | Disclaimer | Colofon

Stichting HIV Monitoring

SHM, the Dutch HIV monitoring foundation, makes an important and necessary contribution to healthcare for HIV-infected people living in the Netherlands. Through the collection and maintenance of anonymous data from HIV-patients throughout the country, our work contributes significantly to the knowledge of HIV and enables treating physicians to assess and improve patient care. Our yearly monitoring report provides valuable input for the development of HIV care and prevention policies within the Netherlands and the EU.